Predicting lithium response in difficult depression
Part of Blood & lymphatic, Cancer, Immune system & allergy, Mental health clinical trials.
This study looks at how to predict which people with hard-to-treat depression will benefit from adding lithium to their antidepressant. If you have treatment-resistant depression and are considering lithium, this trial may help find the best treatment for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with major depressive disorder (a type of depression) that hasn't improved with at least one antidepressant
- Your doctor has recommended a medication called lithium
- You have never had a manic or hypomanic episode (extremely high energy or mood)
- You have not had electroconvulsive therapy (ECT) or repetitive transcranial magnetic stimulation (rTMS) for this current depressive episode
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if lithium can help prevent mood episodes from returning in people with bipolar disorder or major depressive disorder. It aims to see if lithium is a safe and effective longer-term treatment.
Researchers are studying what factors help predict how well people respond to depression treatment. By joining, you'll help them learn more about which treatments work best for different people, and you'll receive standard care with a one-month check-in.
This study tests a new way to deliver lithium, a common treatment for bipolar disorder, using tiny gold particles. It aims to see if this method is safe and effective in laboratory models, which may lead to better treatments with fewer side effects.
This trial looks at how lithium affects the brain in healthy people, to better understand bipolar disorder. You will not receive lithium as a treatment but as a research tool, and you'll have brain scans.
This trial tests an investigational drug called LB-102 for people with bipolar I disorder who are currently experiencing a major depressive episode without psychosis. It aims to see if the drug is safe and effective for treating depression symptoms.
This study looks at how lithium works in everyday life for people with bipolar disorder. It aims to learn about real-world treatment patterns and outcomes.
Hear when a new Depressive; Disorder, Major, Single Episode, Major, With Psychotic Symptoms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.